Key statistics
On Friday, Geron Corp (0IV3:LSE) closed at 4.05, -24.15% below its 52-week high of 5.34, set on Jun 12, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | 4.05 |
Low | 4.05 |
Bid | -- |
Offer | -- |
Previous close | 4.04 |
Average volume | 13.69k |
---|---|
Shares outstanding | 604.50m |
Free float | 603.98m |
P/E (TTM) | -- |
Market cap | 2.43bn USD |
EPS (TTM) | -0.3221 USD |
Data delayed at least 20 minutes, as of Nov 22 2024 15:17 GMT.
More ▼
Press releases
- Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Geron Corporation Announces Appointment of Joseph Eid, M.D. as Executive Vice President, Research and Development
- Geron to Participate in the Stifel 2024 Healthcare Conference
- Geron Corporation Announces Up to $375 Million in Funding with Royalty Pharma and Pharmakon Advisors
- Geron Corporation Reports Third Quarter 2024 Financial Results and Recent Business Highlights
- Geron Announces New Data to be Presented at Upcoming ASH Annual Meeting Highlighting the Potential of RYTELO™ (imetelstat) in Myeloid Hematologic Malignancies
- Geron to Announce Third Quarter 2024 Financial Results on November 7, 2024
- Geron Corporation Announces Appointment of Jim Ziegler as Chief Commercial Officer
More ▼